Cancer research advances in the past few decades have slashed mortality rates, especially for the most fatal cancers.

After increasing for more than 25 years, lung cancer death rates are finally leveling off among women in European Union (EU) ...

The American Cancer Society’s latest Cancer Statistics report reveals that the U.S. five-year survival rate for all cancers ...

A new report from the American Cancer Society shows cancer survival rates here in the U.S. have reached a new milestone.

The known prostate cancer drug, Abiraterone, will be accessible for patients in the coming week, after a campaign led by a ...

Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...

Cancer researchers have a new tool at their disposal that could help improve survival rates. Developed by University of Texas ...

For the first time, patients whose prostate cancer has not spread will be eligible for the drug abiraterone in England, after ...

Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.

The 2026 cancer statistics reveal improved survival rates but highlight persistent inequities in cancer incidence and ...

The American Cancer Society’s annual report found that 70% of patients now survive at least five years after diagnosis.

A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of ...